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Abstract
Exposure to traumatic stress is associated with increased risk for posttraumatic stress disorder
(PTSD) and alterations of hypothalamic-pituitary-adrenocortical (HPA) function. Research linking
traumatic stress with HPA function in PTSD has been inconsistent, however, in part due to (a) the
inclusion of trauma-exposed individuals without PTSD (TE) in control groups and (b) a failure to
consider comorbid major depressive disorder (MDD) and moderating variables. This meta-
analysis of 47 studies (123 effect sizes, N=6,008 individuals) revealed that daily cortisol output
was lower for PTSD (d=−.36, SE=.15, p=.008) and PTSD+MDD (d=−.65, SE=.25, p=.008)
groups relative to no trauma controls (NTC); TE and NTC groups did not differ significantly from
each other. Afternoon/evening cortisol was lower in TE (d=−.25, SE=.09, p=.007) and PTSD (d=
−.27, SE=.12, p=.021) groups and higher in PTSD+MDD groups (d=.49, SE=.24, p=.041) relative
to NTC. Post-DST cortisol levels were lower in PTSD (d=−.40, SE=.12, p<.001), PTSD+MDD
(d=−.65, SE=.14, p<.001), and TE groups (d=−.53, SE=.14, p<.001) relative to NTC. HPA effect
sizes were moderated by age, sex, time since index event, and developmental timing of trauma
exposure. These findings suggest that enhanced HPA feedback function may be a marker of
trauma-exposure rather than a specific mechanism of vulnerability for PTSD, whereas lower daily
cortisol output may be associated with PTSD in particular.
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Traumatic stress is characterized by the direct experience or witnessing of actual or
threatened death or serious injury, or a threat to physical integrity, and responses that
include intense fear, helplessness, or horror (American Psychiatric Association, 2000).
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Epidemiological studies indicate that 82% of individuals in the U.S. have experienced at
least one traumatic event in their lifetime (Sledjeski, Speisman, & Dierker, 2008). Exposure
to trauma dramatically increases vulnerability to a variety of psychiatric disorders, most
commonly Posttraumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD).
Estimates of the conditional risk for developing these disorders in the context of trauma vary
widely and underscore their complex etiologies.
Approximately 8 to 18% of trauma-exposed individuals develop PTSD (e.g., Breslau et al.,
1998; Kessler, Sonnega, Hughes, & Nelson, 1995; Sledjeski et al., 2008) and 7 to 19%
develop MDD (e.g., MacMillan et al., 2001; Shalev et al., 1998). Moreover, rates of
comorbid MDD among individuals meeting diagnostic criteria for PTSD have been reported
to be as high as 37% (e.g., Breslau, Davis, Andreski, & Peterson, 1991). Examining
differences in the way individuals with PTSD with or without MDD respond to stress and
comparing them to individuals exposed to trauma (TE1) who do not develop PTSD (with or
without MDD) may help identify possible mechanisms underlying vulnerability to these
disorders. In addition, contrasting individuals with PTSD to those with PTSD+MDD may
further our understanding of such comorbidity in relation to the stress response. Therefore,
the goal of the current meta-analysis was to examine alterations of the stress response
system in individuals diagnosed with PTSD or PTSD+MDD as compared to trauma-exposed
(TE) individuals without PTSD or MDD, and never-traumatized controls (NTC).
Stress Response System
The hypothalamic-pituitary-adrenocortical (HPA; Stratakis & Chrousos, 1995) axis is one of
three major systems activated as part of the stress response (Teicher, Andersen, Polcari,
Anderson, & Navalta, 2002) and is a potential source of vulnerability to trauma-related
psychopathology (e.g., Yehuda, 2002). The stress response system promotes adaptation, or
allostasis, by allowing organisms to accommodate to changing conditions in their
environment (McEwen & Seeman, 1999). Stress exposure triggers emotional responses,
including activation in the limbic system that initiates HPA activity via connections with the
hypothalamus. Neurons in the paraventricular nucleus of the hypothalamus then secrete
corticotropin releasing hormone (CRH), which travels through the hypophyseal portal
circulation and stimulates the anterior pituitary to release adrenocorticotropin hormone
(ACTH). The ACTH signal, in turn, is carried through the peripheral circulation to the
adrenal cortex where it triggers the production and release of cortisol, a glucocorticoid
hormone responsible for a variety of regulatory functions in the central nervous system,
metabolic system, and immune system (Sapolsky, Romero, & Munck, 2000). This entire
process is referred to here as HPA feed-forward function. Elevated cortisol levels typically
inhibit the HPA via negative feedback mechanisms in the pituitary, hypothalamus, and
hippocampus (Jacobson & Sapolsky, 1991; Munck, Guyre, & Holbrook, 1984; Sapolsky,
Krey, & McEwen, 1986). This latter process reflects HPA feedback function. Thus, the HPA
axis plays an important role in both the stress response and the maintenance of homeostasis
(Sapolsky, 1992).
Basal cortisol activity throughout the day represents an aggregation of circadian oscillations
and superimposed activation related to stressful challenges. Basal cortisol levels can be
measured from samples of saliva, blood, urine, or cerebrospinal fluid. Each of these
measures of cortisol output offers unique temporal foci on diurnal HPA functioning, with
saliva and blood samples reflecting activity within a 10-60 minute window, and urine
samples reflecting activity over a 15-24 hour period (Baum & Grunberg, 1995). Diurnal
rhythm of cortisol levels vary, typically increasing in the early morning, peaking
1TE = trauma-exposed individuals without PTSD or PTSD+MDD
Morris et al. Page 2













approximately 15-30 minutes after awakening (Schmidt-Reinwald et al., 1999), diminishing
over the course of the day, and reaching a nadir at the end of the activity phase (Bailey &
Heitkemper, 1991). Thus, the measurement of cortisol may vary depending on the method
used and time period assessed. Blood and saliva samples are appropriate for measuring
cortisol activity when timing is important (e.g., morning/afternoon cortisol). In contrast,
both urinary cortisol and an average of multiple saliva/blood samples over the day are
appropriate for assessing daily output.
Although elevated cortisol levels are adaptive in the short-run, prolonged activation of the
HPA-axis can have adverse effects (McEwen, 2003). This cumulative physiological wear
and tear, termed allostatic load, can be caused by frequent stress, and the failure to (a)
habituate to recurring stress, (b) inhibit allostatic processes following termination of stress,
or (c) mount an adaptive response in some systems that can lead to the hyperactivation of
others (McEwen, 1998). Cortisol is an important mediator of allostasis that contributes to
allostatic load when it is not efficiently regulated.
One method of assessing cortisol regulation is to examine HPA basal activity and feedback
function. These features indicate how effectively cortisol secretion is inhibited as well as
patterns of output over the course of the day. Previous meta-analyses have examined basal
cortisol levels (Klaassens, Giltay, Cuijpers, van Veen, & Zitman, in press; Meewisse,
Reitsma, De Vries, Gersons, & Olff, 2007) and HPA feedback function (Klaassens et al., in
press; Miller, Chen, & Zhou, 2007) in adults with and without PTSD. The present meta-
analysis expands upon these reviews by addressing three important gaps in the literature.
First we assessed features of HPA feedback function separately for PTSD and PTSD+MDD
groups. Whereas prior reviews suggest that PTSD and MDD are each associated with very
different patterns of cortisol activity (e.g., Kendall-Tackett, 2000), cortisol levels among
individuals with PTSD and comorbid MDD have not been systematically evaluated with
regard to HPA feedback function. Given high rates of comorbid MDD among individuals
with PTSD (Breslau et al., 1991), this represents a critical gap in the literature. Second, we
examined the impact of time of measurement on HPA basal activity effect sizes in addition
to overall daily cortisol output. This is the first meta-analysis to address this question among
TE and PTSD+MDD groups. Third, we examined the role of potential moderators of HPA
basal activity and feedback function effect sizes, including age, sex, time since onset of focal
trauma, and developmental timing of trauma exposure. This is the first meta-analytic review
to evaluate the role of time since onset and developmental timing in TE and PTSD+MDD
groups.
Whereas PTSD has been associated with lower basal cortisol activity, enhanced HPA
feedback function, and a progressive sensitization of the HPA-axis, MDD has been
associated with elevated basal cortisol activity, impaired HPA feedback function, and a
progressive desensitization of the HPA-axis (Kendall-Tackett, 2000). Although considerable
attention has focused on differences in HPA function between individuals with PTSD and
MDD, less is known about the stress response in those with comorbid PTSD and MDD. The
current meta-analytic review addressed three fundamental questions regarding HPA function
in trauma-exposed individuals: (a) Do individuals with TE, PTSD, or PTSD+MDD differ
from never-traumatized controls (NTC) with regard to basal cortisol activity and feedback
functioning? (b) Do individuals with TE, PTSD, or PTSD+MDD differ from each other on
these features of HPA function? (c) Are the relations between trauma-exposure and HPA
function moderated by person (i.e., age, sex) and trauma (i.e., time since onset,
developmental timing) features? Another relevant comparison group would be trauma-
exposed individuals with MDD only (TE+MDD), but a paucity of studies examining HPA
activity in this group precluded including them in the current analyses. Because of the
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conceptual importance of this group, however, we discuss available findings from studies of
individuals with TE+MDD regarding HPA basal activity and feedback functioning.
Basal HPA activity
Morning cortisol levels
Patterns of HPA activity over the course of the day are influenced by internal factors, such
as the suprachiasmatic nucleus in the hypothalamus that regulates circadian rhythms and the
timing of the sleep-wake cycle (Weitzman, Czeisler, Zimmerman, & Moore-Ede, 1981), as
well as cues from the environment. For example, the magnitude of the cortisol awakening
response may be influenced by the experiences of the prior day (Adam, Hawkley, Kudielka,
& Cacioppo, 2006). In addition, psychopathology may moderate the relations between
external factors and basal HPA activity. For instance, social interactions are associated with
steeper rates of decline in cortisol levels over the day in healthy controls but not in
individuals with MDD (Stetler, Dickerson, & Miller, 2004). Indeed, a meta-analysis of
depression and cortisol responses to stress revealed that depressed individuals (not
necessarily in the context of trauma) had lower basal cortisol levels in the morning as
compared to healthy controls (Burke, Davis, Otte, & Mohr, 2005). Studies examining basal
cortisol activity in trauma-exposed individuals suggest that morning cortisol levels may be
lower in TE individuals relative to NTC (Gunnar & Vazquez, 2001), whereas morning
cortisol levels in TE+MDD (Juruena et al., 2006), PTSD, and PTSD+MDD groups
(Meewisse et al., 2007; Miller et al., 2007) may not differ significantly from NTC.
Afternoon cortisol levels
Afternoon cortisol levels may be affected by exposure to stressful interpersonal interactions
characterized by social-evaluative threat during the day. In particular, individuals whose
social status is threatened may exhibit elevated afternoon cortisol levels, with shame
possibly mediating this relation (Dickerson & Kemeny, 2004). Social withdrawal in
response to feelings of loss elicits a flat diurnal profile that may reflect dysregulated
circadian rhythms (Stetler, Dickerson, & Miller, 2004; Stetler & Miller, 2005). Elevated
afternoon cortisol levels have been found in individuals with MDD both with (Juruena et al.,
2006) or without trauma (Burke et al., 2005) relative to healthy controls. Previous studies
have found similar afternoon cortisol levels in TE compared to NTC individuals (Gunnar &
Vazquez, 2001), lower afternoon cortisol levels in PTSD individuals relative to NTC (e.g.,
Meewisse et al., 2007), and higher afternoon cortisol levels in PTSD+MDD individuals
relative to NTC (Young & Breslau, 2004).
Daily cortisol output
Studies of daily cortisol output indicate chronic hypersecretion in individuals with MDD
(trauma-exposure not indicated) (Plotsky, Owens, & Nemeroff, 1995) and increased daily
output of cortisol in individuals with TE+MDD (Juruena et al., 2006; Kosten, Wahby,
Giller, & Mason, 1990). A recent meta-analysis focusing on trauma exposure in adults found
no differences in basal cortisol levels between TE and NTC groups or between TE and
PTSD groups; however, this review did not examine the possible influence of the timing of
measurement (Klaassens et al., in press). We predicted lower daily cortisol output in
individuals with TE or PTSD relative to NTC (Gunnar & Vazquez, 2001; Miller et al.,
2007). Due to inconsistencies in the literature, however, we were not able to make
predictions regarding daily cortisol output for PTSD+MDD compared to NTC groups.
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HPA feedback activity is measured by the rate at which cortisol levels decline following
offset of a stressor and is influenced by a variety of factors, including functioning of the
feedback arm of the HPA-axis and cognitive and affective processes (McEwen, 1998). The
dexamethasone suppression test (DST) measures the extent to which administration of
dexamethasone (DEX), a synthetic glucocorticoid, suppresses production of cortisol in the
HPA axis. Post-DST cortisol levels are presumed to reflect the strength of negative feedback
inhibition, with lower levels indicating stronger suppression.
Studies examining cortisol suppression in patients with MDD typically have administered
either 0.5 or 1.0 mg DEX, and have found abnormal feedback inhibition in the form of
nonsuppression (also termed “early escape”) from the DST in approximately 40-60% of
depressed patients (Carroll & Curtis, 1976; Carroll et al., 1980; see Ribeiro, Tandon,
Grunhaus, & Greden, 1993 for a review). In these studies, nonsuppression was defined as a
failure to suppress cortisol levels below 5.0μg/100 dL in response to 1.0mg DEX. Evidence
concerning the efficiency of negative feedback mechanisms in TE+MDD groups is scant,
but conforms to prior research on depression. Higher post-DST cortisol levels in individuals
with TE+MDD have been reported in two studies (Juruena et al., 2006; Kosten et al., 1990).
Overall, evidence indicates that TE+MDD is associated with impaired negative feedback.
Based on a recent meta-analysis (Klaassens et al., in press), we hypothesized that the TE
group would show enhanced HPA negative feedback as reflected in lower post-DST cortisol
levels relative to NTC. Results of DST studies administering 0.25 or 0.5 mg DEX in
individuals with PTSD have shown lower post-DST cortisol levels than NTC (e.g., Griffin et
al., 2005; Stein, Yehuda, Koverola, & Hanna, 1997; Yehuda et al., 1993; Yehuda et al.,
2002), suggesting enhanced negative feedback or “super suppression.” A similar pattern
appears to hold for individuals with PTSD+MDD (e.g., de Kloet et al., 2007; Yehuda et al.,
1993). Therefore, we expected to find enhanced HPA negative feedback in both PTSD and
PTSD+MDD groups.
Moderators of HPA Activity Following Trauma Exposure
Age
Patterns of basal HPA activity and feedback function change across development. A positive
correlation has been found between age and diurnal cortisol secretion, with levels rising
gradually during middle childhood and then more rapidly in adolescence (Walker, Walder,
& Reynolds, 2001). Studies of HPA function in older adults reveal elevated basal levels
(e.g., Deuschle et al., 1997). Studies of both psychological and biological challenge tests
have found impaired HPA feedback function in older versus younger participants (Otte,
Hart, Neylan, Marmar, Yaffe, & Mohr, 2005). Seeman and Robbins (1994, p. 233) observed
that “age-related changes appear primarily in the re-setting of the HPA axis following a
challenge,” and speculated that such a pattern could result from cumulative exposure to
glucocorticoids. The current meta-analysis extends findings from previous reviews
(Klaassens et al., in press) by examining age as a predictor of HPA basal activity and
feedback functioning effect sizes in PTSD+MDD groups versus NTC.
Sex
Lifetime prevalence rates of both MDD and PTSD are twice as high in females as males
(e.g., Breslau et al., 1998; Kessler et al., 1995). Although men are at greater risk for
exposure to potentially traumatic events (Olff, Langeland, Draijer, & Gersons, 2007), the
conditional risk of developing PTSD after trauma exposure is twice as high in women (e.g.,
Giaconia, Reinherz, Silverman, Pakiz, Frost, & Cohen, 1995). Among healthy controls,
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diurnal cortisol levels appear to be lower in women than in men (Van Cauter, Leproult, &
Kupfer, 1996). Studies using biological challenge tests have found either no significant sex
differences or decreased feedback sensitivity in females (e.g., Heuser et al., 1994; Otte et al.,
2005). Regarding diurnal plasma cortisol levels, women with PTSD had significantly lower
levels than healthy controls, whereas no significant differences have been found between
men with and without PTSD (Meewisse et al., 2007). The current meta-analysis is the first
quantitative review of sex differences in HPA basal activity and feedback function effect
sizes in PTSD+MDD groups relative to NTC.
Time since onset of focal trauma
An inverse relation has been found between HPA activity and months since onset of chronic
stress, such that morning cortisol levels, daily cortisol volume, and post-DEX cortisol levels
decrease over time (Miller et al., 2007). A similar pattern appears to hold for traumatic
stress, with studies showing decreases in cortisol levels following a focal event (Rasmusson
et al., 2001; Yehuda, Halligan, & Grossman, 2001; although see Meewisse et al., 2007).
Yehuda and colleagues (2004a) found a positive association between amount of cortisol
suppression following low dose DST and the number of years since the most recent
traumatic event.
Stressful life experiences may trigger initial increases in cortisol levels that precipitate a
counter-regulatory response. Over time, however, these levels may diminish and eventually
rebound to below normal (e.g., Hellhammer & Wade, 1993; Miller et al., 2007). This
potentially adaptive regulatory response may involve a progressive strengthening of
negative feedback inhibition (Yehuda, 2002). Traumatic life events - although initially
associated with elevations in cortisol and catecholamines - may trigger a divergence in these
measures over time culminating in the pattern of low cortisol and high noradrenaline levels
typical of adults with chronic PTSD (Pervanidiou, 2008). The current meta-analytic review
builds on prior work examining PTSD groups (Meewisse et al., 2007; Miller et al., 2007) by
examining time elapsed since focal trauma as a potential predictor of effect sizes
representing differences in HPA basal activity and feedback functioning between TE and
PTSD+MDD groups relative to NTC.
Developmental timing of trauma exposure
The impact of a traumatic event on HPA-axis functioning may depend on the developmental
epoch in which it occurs, with childhood being an important window of vulnerability to the
effects of stress. Early exposure to trauma is associated with elevated risk for MDD
(Kaufman & Charney, 2001; Pervanidou, 2008) and appears to impact diurnal cortisol
rhythm (e.g., Carpenter et al., 2007; Heim et al., 2000). For example, young children who
have experienced neglect have been found to have blunted early morning peak cortisol
levels and an absence of typical decline over the course of the day (e.g., Carlson & Earls,
1997; Fisher, Gunnar, Chamerblain, & Reid, 2000). The current meta-analysis complements
the recent meta-analytic review of trauma exposure during adulthood (Klaassens et al., in
press) by examining developmental timing as a predictor of HPA basal activity and feedback
function effect sizes.
Summary
The primary goals of the present review were to examine cortisol activity among trauma-
exposed individuals without either PTSD or MDD (TE), and among individuals with PTSD
and PTSD with comorbid MDD, in order to identify features of HPA function that are
uniquely associated with PTSD. Using meta-analytic techniques, we estimated the
magnitude of cortisol levels under basal and biological challenge conditions in individuals
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with TE, PTSD, and PTSD+MDD as compared to never-traumatized controls (NTC).
Because too few studies were available for persons with TE+MDD, this group could not be
included in the meta-analysis.
Prior qualitative reviews exist regarding HPA function in PTSD (e.g., de Kloet et al., 2006;
Yehuda, 2002, 2006) and MDD (e.g., Heim et al., 2008) across multiple outcomes, diverse
methodologies, and with sensitivity to comorbidity. Meta-analyses also have been conducted
examining basal HPA activity and feedback functioning in depressed children and
adolescents (Lopez-Duran, Kovacs, & George, 2009) and in individuals with PTSD and
MDD (Klaassens et al., in press; Miller et al., 2007), and diurnal cortisol parameters in
persons with PTSD and PTSD+MDD (Klaassens et al., in press; Meewisse et al., 2007).
Building on this prior research, the current meta-analysis reviewed studies examining HPA
basal activity and feedback functioning in trauma exposed individuals, distinguishing those
with PTSD versus PTSD+MDD, and identifying factors that may have contributed to
various inconsistencies in this literature.
We examined cortisol outcome variables (i.e., morning levels, afternoon/evening levels,
daily output, post-DST levels) in separate analyses and identified the relations of TE, PTSD,
and PTSD+MDD to these outcomes, which allowed us to balance the need for studies
differing enough for comparisons to be fruitful yet similar enough to render comparisons
meaningful. These meta-analytic models addressed three critical questions: (1) What
alterations of cortisol secretion are associated with trauma exposure in general (i.e., common
to both TE and PTSD groups) and which are specific to PTSD? (2) How does HPA feedback
function in individuals with PTSD and those with PTSD and comorbid MDD? and (3) To
what extent do HPA feedback function effect sizes in TE, PTSD, and PTSD+MDD




Articles for this meta-analysis were identified through searches of PsycINFO, Web of
Knowledge, and PubMed databases and included all studies published through December
2011. Initial searches crossed keywords reflecting traumatic stress (abuse, accidents, assault,
combat, loss, maltreatment, neglect, rape, refugees, terrorism, torture, trauma, veteran, and
war) and trauma-related psychopathology (major depressive disorder, MDD, posttraumatic
stress disorder, PTSD) with those reflecting tests and indicators of HPA function
(adrenocortical, cortisol, dexamethasone, glucocorticoid, HPA). In addition, we searched
reference sections of qualifying articles as well as recent reviews (de Kloet et al., 2006;
Delahanty & Nugent, 2006; Heim et al., 2008; Meewisse et al., 2007; Pervanidou, 2008;
Tarullo & Gunnar, 2006; Yehuda, 2002, 2006; Yehuda & LeDoux, 2007) for any studies not
detected in our initial search.
To be included in this meta-analysis, a study had to (a) enroll participants exposed to
traumatic events and diagnosed with current PTSD or PTSD+MDD, as defined in the
Diagnostic and Statistical Manual (DSM-III, DSM-III-R, or DSM-IV; American Psychiatric
Association, 1980, 1987, 1994) or trauma-exposed participants without current PTSD or
MDD, (b) include a never-traumatized control (NTC) group, (c) measure basal cortisol
levels or post-DST cortisol levels, (d) include sufficient data to compute effect sizes, and (e)
be published in an English-language scientific journal or abstracted in Dissertation Abstracts
International. Traumatic events were defined as circumstances in which an individual
experienced or witnessed “events that involved actual or threatened death or serious injury,
or a threat to the physical integrity of self or others” (American Psychiatric Association,
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2000). Psychiatric groups consisted of individuals meeting DSM-IV (American Psychiatric
Association, 2000) criteria for current PTSD or PTSD+MDD; those who only met criteria
for lifetime, 12-month, or subthreshold diagnoses were excluded from analyses. In addition
to including studies of basal HPA activity, the current meta-analysis reviewed studies
employing the DST. When the results of a single study were reported in multiple articles,
only effect sizes from the publication with the most participants were included.
Studies that included trauma-exposed participants with current MDD were excluded unless
only a small minority (<10%) of TE participants met criteria for current MDD (Yehuda et
al., 2005); for studies in which current MDD was not assessed, TE groups were included if
they represented a sufficiently large sample size (n >70) for expected rates of MDD to exert
minimal influence on cortisol outcomes (Boscarino, 1996; Pervanidou et al., 2007). One
study included TE participants with current dysthymia (De Bellis et al., 1994); removing this
study did not significantly alter results. Only a subset of articles assessed rates of lifetime
psychopathology other than PTSD or MDD in NTC (n = 32; see Data Supplement 2), or TE
(n = 12; Bremner et al., 2007; Carpenter et al., 2007; de Kloet et al., 2007; Golier et al.,
2006, 2007; Newport et al., 2004; Pervanidou et al., 2007; Pfeffer et al., 2007; Yehuda et al.,
2002; Yehuda, Golier, et al., 2004; Yehuda, Halligan, et al., 2004; Yehuda, Kahana, et al.,
1995). Of these studies, four reported lifetime psychopathology in NTC groups (Carpenter et
al., 2007; Pfeffer et al., 2007; Rasmusson et al., 2001; Yehuda, Golier, et al., 2004) and six
reported lifetime psychopathology in TE groups (Bremner et al., 2007; Carpenter et al.,
2007; de Kloet et al., 2007; Newport et al., 2004; Yehuda et al., 2002; Yehuda, Kahana, et
al., 1995). We did not exclude these studies with NTC or TE groups reporting lifetime
psychopathology from the meta-analytic models due to their small number.
The initial search yielded 249 articles that assessed participants for posttraumatic stress
symptoms and measured cortisol levels (for details, see Data Supplement 1). Of these
articles, 79 were excluded because they did not include a never-traumatized control group;
another 63 studies were excluded because they assessed PTSD or MDD symptoms, but not
disorders; 29 studies employed psychosocial or neuroendocrine challenges not examined in
this meta-analysis; 24 did not examine PTSD and PTSD+MDD separately; 6 were excluded
because they only assessed lifetime PTSD or combined participants with lifetime and
current PTSD; 6 failed to report necessary statistics to compute effect sizes and requested
information could not be obtained from corresponding authors; 3 reported data from larger
studies already included in the meta-analysis; and 1 study combined participants with
Depressive Disorder NOS and MDD.
Coded Variables
All studies meeting inclusion criteria were coded (by MCM) for methodological, trauma,
and participant features. Independent coding of a randomly selected 20% of the studies was
done by a second trained coder. Reliabilities were calculated using intraclass correlations
(r1) for continuous variables and kappa for categorical variables (Orwin, 1994). Disparities
were resolved by consensus.
Time of day (κ = 1.00 for morning studies, κ = .79 for afternoon studies)—Due
to the strong influence of circadian rhythm on levels of cortisol, our analytic strategy took
into account the time of day when cortisol samples were collected. Studies in which
measurements of hormone levels were taken before 12 p.m. were coded as morning (a.m.)
studies and those in which measurements were taken after 12 p.m. were coded as afternoon/
evening (p.m.) studies. To examine diurnal cortisol activity, we ran separate analyses on
morning and afternoon/evening studies. Only studies in which the time of day was the same
for all participants were included in these analyses.
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Participant Features—For each study, we coded the number of participants who were (a)
NTC (inter-rater reliability: r1 = 1.00), (b) TE (r1 = 1.00), (c) PTSD (r1 = 1.00), and (d)
PTSD+MDD (r1=1.00), the mean age of the participants (r1=1.00), and the sex composition
of participants in the study (coded as percent male; r1=1.00).
Time since focal trauma (r1=.98)—To estimate the impact of time passed since trauma
exposure, we coded the mean number of days since onset of the focal trauma. This was
determined by (a) the mean time since onset reported by the article in question or by an
article from the same study, (b) subtracting mean age at onset from the mean age of
participants, (c) requesting mean time since onset from authors, (d) estimating mean time
since onset from historical knowledge (e.g., in the case of participants exposed to combat in
Vietnam we estimated time since onset as days between the date of article publication and
the time when U.S. involvement in the war was at its peak – 1968 – consistent with Miller et
al., 2007; for participants exposed to combat in the Croatian War of Independence, we
estimated time since onset using 1991 - the height of the conflict and ethnic cleansing), (e)
estimating mean time since onset from knowledge of developmental timing (e.g., in the case
of participants exposed to childhood abuse where mean age at onset was not reported we
subtracted 12 years from the mean age of participants), (f) estimating mean time since onset
for veterans based on the mean year of their deployment, (g) estimating mean time since
onset for the modal trauma when multiple focal traumas were reported, or (h) estimating
mean time since onset from the midpoint when a range was reported or from the median
duration. All values were log-10 transformed prior to use in meta-analytic models due to
their nonnormal distributions.
Developmental timing of trauma exposure—For each study we coded whether
participants experienced their focal traumatic event in childhood (r1=1.00), adulthood
(r1=1.00), or if this information was not reported. Child onset was coded if more than 80%
of participants experienced a traumatic event before age 18; adult onset was coded when
more than 80% of participants experienced their focal traumatic event at age 18 or older.
Data Analytic Plan
Study-level effect sizes—We computed effect sizes (Cohen's d) for individual studies by
subtracting the mean cortisol level of the NTC group from the psychopathology groups (i.e.,
PTSD or PTSD+MDD) or non-psychopathology group (i.e., TE) mean and dividing by the
pooled standard deviation (Rosenthal, 1994), when these statistics were reported. Because
studies with larger sample sizes provide more accurate estimates of true population
parameters (Shadish & Haddock, 1994), each effect size was weighted by the inverse of its
variance (Hedges' g) to adjust for possible sample size bias (Hedges & Olkin, 1985). When
descriptive statistics were not reported and authors did not provide requested information,
we computed d from inferential statistics (Hedges & Olkin, 1985; Rosenthal, 1994). Cohen's
d may be conceptualized here as the magnitude of the difference between cortisol levels in
psychiatric or TE groups versus NTC in standard deviation units. The use of d allows
pooling of effect sizes across studies with variability in measurement (i.e., plasma/serum,
saliva, urine) and methodological (e.g., sampling) characteristics. Effect sizes of 0.20 are
considered small, 0.50 moderate, and 0.80 large (Cohen & Cohen, 1983).
Aggregate effect sizes—Similar to the approach used by Miller and colleagues (2007),
we ran separate fixed-effects models for each dependent variable (HPA outcomes: morning
levels, afternoon/evening levels, daily output, post-DST levels) stratified by subgroup (i.e.,
TE, PTSD, PTSD+MDD) to evaluate whether the aggregate effect size differed significantly
from zero (Lipsey & Wilson, 2001). Fixed-effects procedures were used to test hypotheses
regarding HPA function in a particular set of observed studies – those sampling trauma-
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exposed individuals with and without PTSD and/or MDD – rather than to generalize more
broadly. The parameters examined in the current meta-analysis were not assumed to be
randomly sampled from the population due to the relatively strict inclusion/exclusion criteria
used here and the likely omission of relevant studies that differed systematically from those
selected. In such cases, fixed effects models are appropriate (Hedges & Vevea, 1998) and
generally confer increased statistical power (Cohn & Becker, 2003). Results should be
interpreted with caution, however, and should be replicated in independent samples.
For each model, a heterogeneity coefficient (Cochran's Q) was calculated to determine
whether significant between-study variability existed, which then might be explained by
other factors (i.e., moderators). Coefficient Q is a chi-square distributed with k – 1 degrees
of freedom, where k is the number of studies. Summary estimates for TE, PTSD, and PTSD
+MDD groups were based on fixed-effects models using inverse variance weighting (see
Table 1 and Figures 1 and 2). Differences in effect sizes between TE, PTSD, and PTSD
+MDD groups were examined by group analysis with tests of interactions (Altman & Bland,
2003; Matthews & Altman, 1996).
Because the Q test is underpowered for small samples and overpowered for large samples,
we also evaluated inconsistencies in results across studies by calculating the I2 statistic,
which describes the percentage of total variation across studies due to heterogeneity rather
than chance (Higgins, Thompson, Deeks, & Altman, 2003). We assessed the role of
potential predictors using fixed-effects meta-regression for continuous variables (i.e., mean
age, percentage male, time since onset of first/focal trauma) and fixed-effects meta-ANOVA
for dichotomous variables (i.e., developmental timing of trauma exposure) even when
significant heterogeneity was not detected, because heterogeneity estimates have limitations
(Ioannidis, 2008) and moderators have been shown to exert significant influences on
outcomes even under conditions of minimal between-study variability (Hall & Rosenthal,
1995). Forest plots were generated using meta-analysis software (Borenstein, Hedges,
Higgins, & Rothstein, 2005) for daily cortisol output (Figure 1) and post-DST cortisol levels
(Figure 2) showing study-level effect sizes and precision (circles) in addition to aggregate
effect sizes (diamonds).
Dependent data—To ensure that the assumption of independence was not violated in the
meta-analytic models, we took the following precautions. Only one effect size per study was
used to compute aggregate effect sizes. When studies provided more than one effect size due
to multiple psychiatric groups, we selected the d based on the largest group for initial
models examining HPA outcomes. When results for a study were reported in multiple
articles, we computed effect sizes from the largest samples, because estimates based on
larger samples are considered more accurate (Hedges & Vevea, 1998).
Descriptive Findings
Analyses were based on 47 independent studies from 50 published articles and 1 dissertation
(see Data Supplement 2 for detailed study characteristics).2 Qualifying studies are marked
with an asterisk in the reference section. Overall, 123 effect sizes were computed, with each
study contributing an average of 2.4 effect sizes (range = 1-7, SD = 1.6). A total of 6,008
individuals were included across all studies. There were 2,521 TE individuals, 504
individuals with PTSD, 237 with comorbid PTSD+MDD, and 2,746 NTC. Computing the
sampling error of d using the Hedges and Olkin (1985) formula allowed for unequal sample
sizes across psychiatric and control groups.
2The effect size generated from this dissertation study for analysis of daily cortisol output did not represent an outlier.
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Participants were 58% male; average age was 37.14 (range 9 to 71 years old). They
experienced the following traumatic events: 19 studies (40%) included participants exposed
to physical abuse, 17 (36%) experienced sexual abuse, 9 (19%) were emotionally abused, 19
(40%) involved combat/war experience, 3 (6%) were neglected, 3 (6%) involved refugee
status, 8 (17%) were tortured, 12 (26%) experienced serious accidents/disasters, 12 (26%)
involved separation or loss of a major relationship, 13 (28%) witnessed a trauma, and 5
(11%) involved receiving a life-threatening medical diagnosis. Basal cortisol activity was
assessed using HPA outcomes including morning cortisol (k = 49), afternoon/evening
cortisol (k = 26), and daily cortisol output (k = 19). Feedback function of the HPA-axis was
assessed through post-DST cortisol (k =29). Regarding developmental timing, 20 studies
examined childhood trauma, 14 examined trauma during adulthood, and 17 either did not
assess or report data to determine developmental timing. Cortisol was assessed in plasma/
serum (k = 33), saliva (k = 14), urine (k = 9) and cerebrospinal fluid (k = 1). Meta-ANOVA
models examined the influence of measurement type on effect sizes for cortisol outcomes
separately for TE, PTSD, and PTSD+MDD groups. For morning cortisol levels, effect sizes
were significantly lower for saliva versus plasma samples in TE groups (d = −.27 versus .03,
p = .016), and significantly higher for saliva versus plasma samples in PTSD+MDD groups
(d = .25 versus −1.05, p < .001). For afternoon/evening cortisol levels, effect sizes were
significantly lower for plasma versus saliva samples in TE (d = −.74 versus −.15, p = .018)
and PTSD (d = −.64 versus −.01, p = .008) groups. Measurement type was not significantly
associated with daily cortisol output or post-DST effect sizes. For subsequent meta-
regression analyses of a.m. cortisol effect sizes (TE and PTSD+MDD groups) and p.m.
cortisol effect sizes (TE and PTSD groups), measurement type was included as a covariate.
HPA basal activity
Fixed-effects models for HPA outcomes were run stratifying according to TE, PTSD, or
PTSD+MDD groups (Table 1). Among TE groups, analyses revealed lower p.m. cortisol
levels (d = −.25, SE = .09, p = .007) and no differences in a.m. or daily output cortisol levels
relative to NTC. For PTSD groups, a.m. cortisol levels (d = −.28, SE = .08, p < .001), p.m.
cortisol levels (d = −.27, SE = .12, p = .021), and daily cortisol output (d = −.36, SE = .13, p
= .008) were all significantly lower than NTC. Analysis of basal HPA activity in individuals
with PTSD+MDD revealed significantly lower a.m. cortisol (d = −.66, SE = .14, p < .001),
higher p.m. cortisol (d = .49, SE = .24, p = .041), and lower daily cortisol output (d = −.65,
SE = .25, p = .008) as compared to NTC.
Findings regarding HPA basal activity outcomes in TE, PTSD, and PTSD+MDD groups
relative to NTC are presented in Figure 3 (see Figures 1 and 2 for forest plots for these HPA
outcomes). Morning cortisol aggregate effect sizes for PTSD+MDD groups were
significantly lower than those for PTSD (p = .009) and TE (p < .001) groups; morning
cortisol aggregate effect sizes also were lower for PTSD as compared to TE individuals (p
< .001). Regarding afternoon/evening cortisol, effect sizes for individuals with PTSD+MDD
were significantly higher than those for PTSD (p = .005) and TE (p = .004) groups.3 No
significant differences were observed in daily cortisol output effect sizes for the TE, PTSD,
and PTSD+MDD groups.
3We re-ran analyses excluding studies that had TE participants with a history of PTSD (Bremner et al., 2007; Carpenter et al., 2007;
Newport et al., 2004; Yehuda, Kahana, et al., 1995) and NTC participants with a history of PTSD (Pfeffer et al., 2007). For afternoon/
evening cortisol, PTSD groups now showed marginally lower levels (d=−.24, SE=.12, p=.052) and TE groups no longer showed lower
levels relative to NTC.
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Analyses of feedback functioning revealed significantly lower post-DST cortisol levels in
TE (d = −.53, SE = .14, p < .001), PTSD (d = −.40, SE = .12, p < .001) and PTSD+MDD (d
= −.65, SE = .14, p < .001) groups relative to NTC, indicating enhanced suppression (see
Figure 2). No significant differences were found in post-DST effect sizes among TE, PTSD,
and PTSD+MDD groups.
Moderators of HPA function
Age—We examined relations between the mean age of participants and effect sizes for each
HPA outcome using separate meta-regression models for TE, PTSD, and PTSD+MDD
groups. For individuals with PTSD, mean age was negatively associated with post-DST
cortisol (β = −.36, SE = .01, p < .001) effect sizes indicating that enhanced HPA suppression
was linked with older ages. In individuals with PTSD+MDD, daily cortisol output effect
sizes were positively associated with age (β = .67, SE = .04, p = .001) such that greater daily
output was associated with older ages.
Sex—We examined relations between sex composition and effect sizes for each HPA
outcome using separate meta-regression models for TE, PTSD, and PTSD+MDD groups.
Percentage of males was negatively associated with p.m. cortisol effect sizes in TE groups
(β = −.73, SE = .003, p < .001), after controlling for measurement type, with lower p.m.
cortisol associated with a higher percent of males. Percentage of males was negatively
associated with daily cortisol output among PTSD groups (β = −.45, SE = .004, p < .001),
such that lower daily output was associated with having more males. Percentage of males
was negatively associated with post-DST cortisol effect sizes among individuals with PTSD
+MDD (β = −.39, SE = .003, p = .014), such that having more males was associated with
lower post-DST cortisol effect sizes.
Time since onset of focal trauma—We examined relations between time elapsed since
the focal trauma and effect sizes for each HPA outcome using separate meta-regression
models for TE, PTSD, and PTSD+MDD groups. The mean time since onset across all
studies was 17.6 years (SD = 13.2 years; range 1 month to 50 years). Time since trauma
onset was negatively associated with p.m. cortisol effect sizes at the level of a trend (β = −.
27, SE = .18, p = .055) in PTSD groups after controlling for measurement type, indicating
that afternoon cortisol levels were lower for samples in which more time had elapsed since
the focal trauma. Time since trauma onset also was negatively associated with daily output
(β = −.23, SE = .12, p = .038) and post-DST effect sizes (β = −.48, SE = .28, p < .001) in
PTSD groups, such that daily output and post-DST cortisol levels were lower for samples in
which more time had elapsed since the focal trauma. Among individuals with PTSD+MDD,
time since trauma onset was negatively related to daily output effect sizes (β = −.91, SE = .
79, p < .001) and post-DST cortisol effect sizes (β = −.36, SE = .39, p = .024), indicating
that daily output and post-DST cortisol levels were lower for samples in which more time
had elapsed since the focal trauma.
Developmental timing—We examined relations between developmental timing and
effect sizes for each HPA outcome using meta-ANOVA models for TE, PTSD, and PTSD
+MDD groups. Trauma in childhood was examined in 14 studies, trauma during adulthood
was examined in 20 studies, and 17 studies did not report sufficient information to make this
determination. Developmental timing was not significantly associated with morning cortisol
effect sizes for TE groups, controlling for measurement type, or for PTSD groups. However,
results revealed that morning cortisol effect sizes were significantly lower for adult versus
childhood trauma exposure (d = −1.40 versus −.01, p < .001) in individuals with PTSD
+MDD. Developmental timing was not significantly associated with afternoon/evening
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cortisol or daily output effect sizes for TE or PTSD groups. There was insufficient data to
examine the influence of developmental timing on p.m. cortisol or daily output effect sizes
in individuals with PTSD+MDD. Developmental timing was not significantly associated
with post-DST cortisol effect sizes for TE groups. Post-DST cortisol effect sizes were
significantly lower for adult as compared to childhood trauma exposure for individuals with
PTSD+MDD (d = −.96 versus −.04, respectively, p = .006) and at the level of a trend for
individuals with PTSD (d = −.60 versus −.12, respectively, p = .053).
Finally, we examined whether relations between time since trauma onset and HPA outcomes
remained after controlling for developmental timing. Preliminary analyses revealed no
significant differences in time since onset between studies of child versus adult trauma
exposure [t(26) = 1.51, p = .144]. Nevertheless, we explored whether including
developmental timing as a covariate altered findings from meta-regression models
examining the association between time since onset and cortisol effect sizes. Results of
analyses of morning cortisol effect sizes were not changed. Developmental timing
significantly predicted morning cortisol effect sizes for PTSD+MDD groups (β = .59, SE = .
32, p < .001), controlling for time since onset, indicating that childhood trauma was
associated with higher morning cortisol levels as compared to adult trauma exposure in
individuals with PTSD+MDD.
For afternoon/evening cortisol, after controlling for developmental timing, time since trauma
onset was negatively associated with effect sizes for TE groups (β = −.51, SE = .27, p= .010)
and PTSD groups (β = −1.28, SE = .23, p = .006), indicating that p.m. cortisol levels were
lower for samples in which more time had elapsed since the focal trauma. Results of
analyses examining daily cortisol output were not altered when controlling for
developmental timing. Finally, post-DST cortisol effect sizes were significantly associated
with time since trauma onset (β = −.57, SE = .34, p < .001), but not developmental timing,
for PTSD groups. For individuals with PTSD+MDD, results continued to show that post-
DST effect sizes were lower for adult as compared to childhood trauma exposure (β = −.43,
SE = .34, p = .010); the relation between time since trauma onset and post-DST effect sizes
was no longer significant.
Discussion
The primary aim of the current meta-analytic review of 47 independent studies was to
determine whether trauma-exposed individuals with PTSD, PTSD+MDD, or neither (TE)
differed from never traumatized controls (NTC) and from each other regarding HPA basal
activity and feedback functioning. We were particularly interested in identifying features of
HPA function that distinguished trauma-exposed individuals who developed PTSD from
those who did not, and whether individuals with PTSD versus those with PTSD+MDD
could be distinguished by patterns of HPA function. Finally, we examined whether the
relations between trauma-exposure and HPA function were moderated by person and trauma
features.
HPA basal activity
Meta-analytic models revealed that morning cortisol levels were lower in PTSD and PTSD
+MDD groups relative to NTC. This finding contrasts with the results of earlier meta-
analyses showing no significant differences in morning cortisol levels between adults with
PTSD and healthy controls (Meewisse et al., 2007; Miller et al., 2007). Our analyses of
morning cortisol levels, however, included over twice as many studies (i.e., 33 versus 15) as
had been available at the time of the earlier meta-analyses (e.g., Meewisse et al., 2007), and
therefore we might have had greater power to detect small effect sizes.
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Enhanced HPA negative feedback is associated with diminished basal cortisol activity in
individuals with PTSD (Yehuda et al., 1996). Interestingly, we found that TE individuals
(without PTSD or MDD) exhibited enhanced negative feedback but did not differ
significantly from NTC in their morning cortisol levels. The reason for this apparent
decoupling of HPA feedback function from morning cortisol levels among TE individuals
remains unclear. Given that social interactions exert a regulatory effect on cortisol circadian
rhythm (e.g., Dickerson & Kemeny, 2004; Stetler & Miller, 2005), we speculate that TE
individuals might not experience the same level of disruptions of social behavior observed in
trauma-related MDD (e.g., social withdrawal) and PTSD (e.g., diminished interest or
participation in significant activities, feelings of detachment or estrangement from others).
Consistent with prior research (Meewisse et al., 2007), afternoon/evening cortisol levels
were significantly lower in PTSD groups relative to NTC. Contrary to expectation, however,
a similar pattern was observed in TE individuals. Lower p.m. cortisol levels may be related
to the enhanced suppression of cortisol secretion in trauma exposed individuals without
PTSD or MDD. As anticipated, p.m. cortisol levels were significantly higher in PTSD
+MDD groups compared to NTC. This finding parallels results of a study examining basal
cortisol activity in TE+MDD individuals (Juruena et al., 2006). We speculate that the
presence of comorbid MDD in individuals with PTSD may be associated with alterations in
sensitivity to social-evaluative threat, which has been linked to increased cortisol responses
and recovery times (Dickerson & Kemeny, 2004).
Consistent with expectation, the meta-analytic models revealed lower daily cortisol output in
individuals with PTSD (without MDD) relative to NTC. Interestingly, daily cortisol output
also was lower in PTSD+MDD groups relative to NTC, despite elevated p.m. cortisol levels.
This pattern of results in those with PTSD+MDD is consistent with our prediction of a
flattened diurnal cortisol slope for this group. TE individuals did not differ significantly
from NTC in daily cortisol output, however, despite lower p.m. cortisol levels. In addition,
daily cortisol output effect sizes in TE, PTSD, and PTSD+MDD groups did not differ from
each other. These findings contrast with those from a recent meta-analysis that detected no
significant differences in daily cortisol output among TE, PTSD, and NTC groups
(Klaassens et al., in press). Whereas the current review attempted to capture patterns of
cortisol secretion over the course of the day by examining morning, afternoon/evening, and
daily output effect sizes separately, Klaassens and colleagues (in press) assessed basal HPA
activity without controlling for the time of measurement. Chronobiological studies such as
those conducted with PTSD and MDD groups (Yehuda et al., 1996) are needed to elucidate
patterns of circadian cortisol secretion in TE individuals.
HPA feedback function
In line with expectation that the pattern of HPA feedback function would be characterized
by enhanced negative feedback in TE (e.g., Klaassens et al., in press), PTSD, and PTSD
+MDD groups (Miller et al., 2007), we found that these groups showed lower post-DST
cortisol levels compared to NTC. No significant differences were detected in post-DST
effect sizes among the three trauma-exposed groups. Neurobiological explanations of why
only some trauma-exposed individuals develop PTSD have emphasized the “failure of
mechanisms involved in recovery and restitution of physiological homeostasis, possibly
resulting from individualistic predisposition” (Yehuda & LeDoux, 2007, p. 19). If enhanced
negative feedback explains HPA abnormalities in individuals with PTSD (Yehuda et al.,
1995) and is associated with increased risk for the development of PTSD, then we might not
expect to find it among trauma exposed individuals who do not develop PTSD. The current
meta-analysis, however, found enhanced HPA negative feedback among TE individuals as
well, and the post-DST cortisol effect sizes in TE individuals did not differ significantly
from those with PTSD or PTSD+MDD.
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Two alternative explanations are possible for these findings. First, enhanced HPA feedback
function may not be associated with risk for PTSD in particular, but rather may be linked
with trauma-exposure in general. Second, enhanced HPA feedback function may be
associated with increased risk for PTSD among TE individuals. A recent prospective study
examining post-DST cortisol levels in the aftermath of trauma found that most, but not all,
individuals who developed PTSD showed enhanced negative feedback in response to DEX
challenge (McFarlane, Barton, Yehuda, & Wittert, 2011). That enhanced HPA negative
feedback is only reported in some individuals who develop PTSD, and characterizes some
trauma-exposed individuals who do not develop PTSD, suggests that such enhanced
negative feedback likely is not a specific vulnerability to PTSD (Pitman et al., 2006). These
competing hypotheses could be addressed by prospective studies following TE individuals
to determine whether they are at increased risk of developing PTSD as a function of
enhanced HPA feedback.
Moderators of HPA function
Age—Studies examining the relation of age to HPA function in healthy individuals
generally have found elevated basal activity and impaired feedback functioning in older
samples (Otte et al., 2005). The current meta-analysis investigated age as a possible
moderator of HPA function in TE, PTSD, and PTSD+MDD groups. Meta-regression models
revealed that mean age of participants was negatively associated post-DST cortisol effect
sizes in PTSD groups. That is, among individuals with PTSD, lower post-DST levels were
associated with older ages. For individuals with PTSD+MDD, mean age was positively
associated with daily cortisol output effect sizes, such that greater daily cortisol output was
associated with older ages. Interestingly, mean age was not significantly associated with
HPA basal activity or feedback function in TE individuals. Taken together, these findings
suggest that enhanced HPA negative feedback may characterize older individuals with
PTSD. Additionally, older individuals with PTSD+MDD appear to exhibit greater daily
cortisol output, and therefore may be at increased risk for physical health problems
associated with hypercortisolism (e.g., McEwen, 2007).
Sex—Elevated rates of MDD and PTSD in women relative to men (e.g., Breslau et al.,
1998), coupled with evidence of sex differences in HPA function (e.g., Van Cauter et al.,
1996), suggest that alterations of the stress response may confer increased vulnerability to
psychopathology in women. The current meta-analysis examined whether differences in
HPA function for TE, PTSD, and PTSD+MDD groups relative to NTC varied by sex. Meta-
regression models revealed that the percentage of males in study samples was negatively
associated with afternoon/evening cortisol effect sizes in TE groups, indicating that women
may exhibit more elevated p.m. cortisol output than men. Percentage of males also was
negatively associated with post-DST cortisol effect sizes in PTSD+MDD groups; that is,
among those with PTSD+MDD men appear to show enhanced HPA feedback function
relative to women. In addition, among PTSD groups, having more males was associated
with lower daily cortisol output. Thus, although we anticipated that sex differences in
cortisol outcomes might partially explain increased vulnerability to PTSD among women,
these results indicate that HPA alterations linked to psychopathology are found in both men
(i.e., lower daily cortisol output, lower post-DST cortisol levels) and women (i.e., elevated
afternoon cortisol levels).
Time since onset of trauma—Prior reviews of this literature have reached different
conclusions regarding the relation between time since the onset of the trauma and HPA
function. Whereas one review showed that the amount of time elapsed since the onset of
chronic or traumatic stress was inversely associated with HPA basal activity and feedback
function in individuals with PTSD (e.g., Miller et al., 2007), another reported no significant
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relation of years since trauma to cortisol levels in PTSD groups relative to controls
(Meewisse et al., 2007). The current meta-analysis explored the relation of time since the
trauma to HPA function in TE and PTSD+MDD groups in addition to PTSD groups. Meta-
regression analyses revealed that the time elapsed since focal trauma was associated with
lower p.m. cortisol, daily output, and post-DST cortisol effect sizes in PTSD groups, and
lower daily cortisol output and post-DST effect sizes in PTSD+MDD groups. When
controlling for developmental timing, the time elapsed since focal trauma also was
negatively associated with p.m. cortisol for TE groups, but time since onset was no longer
significantly associated with post-DST cortisol for individuals with PTSD+MDD.
This pattern of HPA activity is consistent with theories positing that the effect of stress on
cortisol secretion is time-dependent; that is, hypersecretion may characterize the short-term
response, whereas hyposecretion may develop in the long-term (Fries et al., 2005;
Hellhammer & Wade, 1993; Miller et al., 2002). Interestingly, the apparent strengthening of
HPA feedback function and diminishing daily cortisol output over time was not observed in
TE individuals. Thus, these time-dependent processes may be involved particularly in the
onset and maintenance of PTSD in response to trauma. Longitudinal studies are needed to
replicate the findings of the current meta-analysis, which were based on cross-sectional
studies of group differences.
Developmental timing—Exposure to traumatic events during childhood is associated
with increased risk for stress-related psychopathology (e.g., Kaufman & Charney, 2001) and
may be linked to alterations of stress response systems including the HPA-axis. Previous
studies have found alterations in diurnal cortisol secretion associated with early adversity
(e.g., Carlson & Early, 1997; Carpenter et al., 2007; Fisher et al., 2000; Heim et al., 2000).
In contrast, a recent meta-analysis reported no differences in basal cortisol levels between
TE and PTSD groups exposed to trauma during adulthood and NTC (Klaassens et al., in
press). Qualitative reviews have shown that maltreated children with internalizing problems
exhibit increased basal HPA activity, particularly elevated morning cortisol secretion,
whereas adults who were maltreated in childhood tend to exhibit decreased basal HPA
activity (Tarullo & Gunnar, 2006). The current meta-analysis expanded upon this literature
by showing that among individuals with PTSD+MDD, trauma exposure during childhood
was associated with higher morning cortisol and post-DST effect sizes relative to trauma
exposure during adulthood, controlling for the time elapsed since the focal traumatic event.
Comorbid PTSD+MDD
Expanding upon a previous review that included only 4 studies of individuals with comorbid
PTSD+MDD (Meewisse et al., 2007), the current meta-analysis included effect sizes from
16 studies (24 effect sizes) of PTSD+MDD groups. Results revealed lower a.m. and higher
p.m. cortisol levels in individuals with PTSD+MDD relative to NTC, as well as compared to
those with PTSD only. Although PTSD+MDD and PTSD only groups had a similar pattern
of enhanced HPA feedback function, their HPA outcomes were differentially associated
with the various moderators tested (i.e., mean age of participants, percentage of males, time
since trauma onset, and developmental timing). Mean age was negatively associated with
post-DST effect sizes in PTSD only groups and positively associated with daily cortisol
output effect sizes in PTSD+MDD groups. Higher percentage of males was associated with
lower post-DST cortisol effect sizes among individuals with PTSD+MDD but not those with
PTSD only. Time since trauma onset was associated with p.m. cortisol effect sizes in PTSD
only but not PTSD+MDD groups. Finally, developmental timing of the trauma was
significantly associated with morning cortisol and post-DST cortisol effect sizes for those
with PTSD+MDD but not for individuals with PTSD only.
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Some researchers have argued that “the bulk of psychopathology in the aftermath of trauma
is best conceptualized as a general traumatic stress factor” (O'Donnell et al., 2004, p. 1395),
with symptoms of PTSD and MDD reflecting shared vulnerability and predictors (Breslau et
al., 2000). Results of the current meta-analysis, however, revealed unique HPA features of
PTSD versus PTSD+MDD in addition to unique predictors of effect sizes. Thus, the
emergence of PTSD only and PTSD+MDD may be governed by both shared and distinct
vulnerability factors. This hypothesis is consistent with the findings of a recent confirmatory
factor analysis revealing that PTSD and MDD are distinguishable constructs in the aftermath
of trauma, although both load on a higher order emotional numbing/dysphoria construct
(Grant, Beck, Marques, Palyo, & Clapp, 2008).
HPA markers of vulnerability to PTSD
Daily cortisol output was lower in both PTSD and PTSD+MDD groups relative to NTC; TE
and NTC groups were not significantly different from each other. Thus, reduced HPA basal
activity may be associated with vulnerability to PTSD. Hellhammer and Wade (1993)
proposed that trauma exposure may trigger a cascade of events among individuals at risk for
PTSD beginning with chronic stress-related CRH hypersecretion associated with recurrent
memories and threat-appraisals of novel situations (Baum, Cohen, & Hall, 1993), followed
by an adaptive down-regulation of pituitary CRH receptors, culminating in cortisol
hyposecretion after a return to normal levels of CRH secretion. Decreased basal cortisol
activity in the aftermath of trauma may interfere with stress recovery processes. In support
of this hypothesis, a double-blind, randomized control study examining recovery from the
potentially traumatic experience of septic shock found a lower incidence of PTSD in patients
who were administered a stress-dosage of hydrocortisone (synthetic cortisol) compared to
patients who were given saline (Schelling, Briegel, Roozendaal, Stoll, Rothenhausler, &
Kapfhammer, 2001). Animal studies have shown that early treatment with high-dose
corticosterone immediately following psychogenic stress reduced prevalence of PTSD-like
behaviors (e.g., cue-induced freezing) relative to a saline control condition (Cohen, Matar,
Buskila, Kaplan, & Zohar, 2008). Finally, prospective studies of trauma exposure in humans
generally have found that lower cortisol levels shortly after a traumatic event are associated
with increased risk for PTSD (Delahanty, Raimonde, & Spoonster, 2000; Ehring, Ehlers,
Cleare, & Glucksman, 2008; McFarlane, Atchison, & Yehuda, 1997; although see Bonne et
al., 2003; Shalev, Videlock, Peleg, Segman, Pitman, & Yehuda, 2008).
Reduced basal cortisol activity following trauma may represent an adaptation to anticipated
threat insofar as it allows the HPA-axis to mount a rapid response to trauma-related cues,
unfettered by ongoing negative feedback that would result from elevated circulating cortisol
levels. Lower daily cortisol output also may serve as a means of increasing preparedness for
real or perceived threats to the physical self by reducing inhibition of inflammatory
processes (e.g., Raison & Miller, 2003). However, in the long-run, a pattern of reduced
cortisol secretion may place individuals with PTSD at greater risk for a variety of health
conditions via a failure to inhibit immune responses, sympathetic nervous system (SNS)
activity, and short-term CRH secretion (Heim et al., 2000; Raison & Miller, 2003). For
example, a lack of cortisol-mediated inhibition of SNS activation in the aftermath of a
traumatic event may lead to hypersecretion of norepinephrine (NE), an ‘overconsolidation’
of trauma-related memories, elevated and sustained hyperarousal related to ‘re-
experiencing’ symptoms, and, ultimately, the development of PTSD (Pitman, 1989; Yehuda
& Harvey, 1997). Over time, individuals may become increasingly sensitized to threats via
disruptions of neural fear and anxiety networks and a progressive divergence of HPA and
SNS activity reflected in decreasing levels of evening cortisol and increasing concentrations
of NE (Pervanidou, 2008).
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Given that most individuals exposed to trauma will not develop PTSD (e.g., Kessler et al.,
1995), researchers have sought to identify pre-trauma risk factors that interact with exposure
to traumatic events to trigger the onset of PTSD. Some individuals may exhibit a relatively
stable pattern of reduced HPA basal activity that places them at greater risk for developing
PTSD when confronted with a traumatic event. For example, children of parents with PTSD
(high risk) are more likely to develop PTSD themselves following trauma-exposure than
children of trauma survivors without PTSD and children of never-traumatized parents.
These high-risk children also exhibit patterns of reduced cortisol secretion over the course of
the day (Yehuda et al., 2007).
Reduced daily cortisol output may represent a relatively stable, pre-existing vulnerability
factor for PTSD, possibly connected to early adversity; in contrast, lower post-DST cortisol
levels may worsen over time as a result of exposure to the traumatic event and its sequelae
(e.g., Yehuda, 2002). The current meta-analysis showed that reduced daily cortisol output
was characteristic of PTSD and PTSD+MDD groups, but not TE groups, and that daily
cortisol output and post-DST cortisol levels were inversely related to the time since trauma
exposure for individuals with PTSD. These findings are consistent with evidence that prior
trauma exposure is associated with both lower cortisol secretion immediately following
trauma exposure and higher risk for subsequent PTSD (Resnick, Yehuda, Pitman, & Foy,
1995).
Reduced daily cortisol output may represent both a relatively stable and a dynamic
vulnerability factor for PTSD; that is, some individuals may be ‘pre-sensitized’ to the effects
of trauma (e.g., based on genetic liability or early adversity), whereas others may become
increasingly sensitized with each trauma exposure. Although results of the current meta-
analysis indicate that HPA basal activity may diminish over time following trauma-exposure
in individuals with PTSD or PTSD+MDD, longitudinal high-risk studies are needed to
determine whether HPA hypoactivity represents a relatively stable preexisting vulnerability
that increases risk for PTSD. Based on the findings regarding TE groups, we speculate that
the maintenance of normative diurnal cortisol secretion in the aftermath of trauma, despite
enhanced HPA negative feedback, may be protective. Future studies should examine
psychosocial factors (e.g., coping factors and social support) potentially associated with this
profile of HPA secretion.
Limitations and Future Directions
Limitations of the current meta-analysis should be noted. First, our analyses were based on
cross-sectional studies and therefore could not address whether observed HPA
characteristics that distinguished TE, PTSD, and PTSD+MDD groups from never
traumatized controls were pre-existing vulnerability factors (i.e., trait markers), emerging
vulnerability factors (i.e., scar markers), or state-like concomitants of trauma (i.e., state
markers). Prospective studies that examine individuals before, during, and after exposure to
traumatic events are needed to identify vulnerability and protective factors for trauma-
related psychopathology. This could be accomplished by selecting children who are at
increased risk based on parental PTSD and/or MDD, but who have not yet been exposed to
trauma or had an episode of either PTSD or MDD, and following them across salient
developmental transitions associated with increased stress (e.g., puberty, school changes,
emerging adulthood).
Second, due to a paucity of relevant studies, we were not able to compute aggregate effect
sizes for individuals with TE+MDD. To disentangle correlates and risk factors associated
with individual and comorbid disorders, more research is needed that examines HPA
function in individuals exposed to trauma who develop MDD only. The current meta-
analysis revealed unique HPA features and predictors associated with PTSD versus PTSD
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+MDD. Future studies should investigate HPA function in PTSD either excluding
individuals with comorbid MDD or recruiting large enough samples to allow assessment of
the unique characteristics and correlates of PTSD versus MDD in traumatized individuals.
Third, despite its widespread use, the DST has several drawbacks. Levels of circulating
glucocorticoids resulting from DEX administration may be much higher than levels of
endogenous cortisol typically elicited in response to psychosocial stressors (Burke et al.,
2005), thereby reducing ecological validity. Moreover, DEX does not readily cross the
blood-brain barrier, preferentially targeting the pituitary and causing only partial depletion
of circulating cortisol in the brain (de Kloet et al., 1998). Hence, the DST does not directly
influence corticolimbic structures. For these reasons, psychosocial stressor paradigms such
as the Trier Social Stress Test (TSST; Kirschbaum et al., 1993) may provide a better
window into processes associated with stress response and recovery.
Fourth, a dearth of studies employing the DEX/CRH challenge to examine the impact of
trauma on negative feedback inhibition prohibited the computation of aggregate effect sizes.
Future research should use this paradigm because it is a more sensitive assessment than the
DST (Holsboer, von Bardeleben, Wiedemann, Muller, & Stalla, 1987), particularly for
examining HPA function in individuals with MDD (Heuser et al., 1994). The recent meta-
analysis by Klaassens and colleagues (in press) included two studies that utilized the DEX/
CRH challenge and found no difference between PTSD and NTC groups. The current meta-
analysis also did not include challenge studies administering metyrapone – a drug that
inhibits an enzyme involved in the synthesis of cortisol. Results of two studies using this
paradigm have failed to demonstrate enhanced HPA feedback function in patients with
PTSD (Kanter et al., 2001; Kellner et al., 2003), thus highlighting the need for more
research in this area.
We were not able to control for lifetime psychiatric diagnoses in TE and NTC groups
because this information was not provided in most studies. Some studies have found that
alterations in HPA function may persist after recovery from depressive episodes and may be
associated with risk for recurrence (e.g., Appelhof et al., 2006; Rao et al, 2010; Zobel et al.,
2001). Future studies including TE and NTC groups without lifetime psychopathology are
needed to address this concern (e.g., Klaassens et al., 2009). Finally, we were unable to
disentangle the relative influence of time since onset of focal trauma and chronicity of
posttraumatic stress symptoms for the PTSD and PTSD+MDD groups because this
information was rarely reported.
Summary and Conclusions
Results of this meta-analytic review revealed reliable differences in HPA outcomes among
TE, PTSD, and PTSD+MDD groups relative to NTC. Lower daily cortisol output and
enhanced HPA feedback function were found in PTSD and PTSD+MDD groups. Comorbid
PTSD+MDD was associated with unique HPA function features (e.g., elevated p.m. cortisol
levels relative to NTC) compared to PTSD alone. Reduced HPA basal activity distinguished
PTSD and PTSD+MDD groups from TE groups, although TE individuals showed enhanced
HPA feedback function similar to both PTSD groups.
In addition, HPA function was differentially moderated by mean age and sex composition of
samples, time elapsed since the index trauma, and the timing of trauma exposure for TE,
PTSD, and PTSD+MDD groups. TE individuals exhibit similar daily cortisol output to
NTC, whereas those with PTSD or PTSD+MDD show reduced daily cortisol output relative
to NTC. Importantly, TE individuals did not differ from PTSD and PTSD+MDD groups
regarding HPA negative feedback function. Thus, whereas considerable attention has
focused on the role of enhanced HPA negative feedback as a possible marker of risk for
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PTSD, the present findings suggest that this alteration may not distinguish trauma-exposed
individuals who will go on to develop PTSD from those who will not. Finally, the current
meta-analytic review showed that reduced daily cortisol output is a potential risk factor for
PTSD and is not simply a marker of trauma exposure. Due to the debilitating nature of
PTSD and its impact on disease outcomes, the identification of early risk factors and
refinement of integrative psychoneuroenocrine models represents a critical avenue for future
research.
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• Daily cortisol output was lower for PTSD and PTSD+MDD groups relative to
NTC
• No significant differences between TE and NTC groups in daily cortisol output
• Afternoon cortisol was lower in PTSD groups relative to NTC
• Afternoon cortisol was higher in PTSD+MDD groups relative to NTC
• Post-DST cortisol levels were lower in PTSD, PTSD+MDD, TE groups relative
to NTC
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Standardized mean differences (with 95% CI) of daily cortisol output levels between
psychiatric subgroups and no trauma controls (NTC). TE = trauma-exposed without PTSD
or MDD; PTSD = Posttraumatic Stress Disorder; PTSD+MDD = PTSD and comorbid Major
Depressive Disorder
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Standardized mean differences (with 95% CI) of post-DST cortisol levels between
psychiatric subgroups and no trauma controls (NTC). TE = trauma-exposed without PTSD
or MDD; PTSD = Posttraumatic Stress Disorder; PTSD+MDD = PTSD and comorbid Major
Depressive Disorder; DST = Dexamethasone Suppression Test
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Mean (± SEM) cortisol effect size (d) for studies examining morning (a.m.), afternoon/
evening (p.m.), daily output, and post-DST levels in TE, PTSD, and PTSD+MDD groups.
TE = trauma-exposed without PTSD or MDD; PTSD = Posttraumatic Stress Disorder;
PTSD+MDD = PTSD and comorbid Major Depressive Disorder; a.m. = morning (before 12
p.m.); p.m. = afternoon/evening (after 12 p.m.); DST = Dexamethasone Suppression Test.
*p<.05; **p<.01;*** p<.001.
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